Thoroughbred Financial Services’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Sell |
5,386
-960
| -15% | -$60.1K | 0.02% | 442 |
|
|
2025
Q1 | $381K | Buy |
6,346
+1,165
| +22% | +$69.9K | 0.02% | 484 |
|
|
2024
Q4 | $302K | Sell |
5,181
-225
| -4% | -$13.1K | 0.02% | 532 |
|
|
2024
Q3 | $320K | Sell |
5,406
-155
| -3% | -$9.18K | 0.02% | 504 |
|
|
2024
Q2 | $311K | Buy |
5,561
+1,116
| +25% | +$62.4K | 0.02% | 492 |
|
|
2024
Q1 | $260K | Sell |
4,445
-1,116
| -20% | -$65.3K | 0.03% | 397 |
|
|
2023
Q4 | $300K | Sell |
5,561
-876
| -14% | -$47.3K | 0.02% | 477 |
|
|
2023
Q3 | $312K | Buy |
6,437
+336
| +6% | +$16.3K | 0.03% | 429 |
|
|
2023
Q2 | $344K | Sell |
6,101
-129
| -2% | -$7.27K | 0.05% | 312 |
|
|
2023
Q1 | $336K | Buy |
6,230
+955
| +18% | +$51.5K | 0.05% | 308 |
|
|
2022
Q4 | $277K | Sell |
5,275
-2,186
| -29% | -$115K | 0.05% | 326 |
|
|
2022
Q3 | $352K | Buy |
7,461
+1
| +0% | +$47 | 0.07% | 250 |
|
|
2022
Q2 | $376K | Buy |
7,460
+76
| +1% | +$3.83K | 0.07% | 247 |
|
|
2022
Q1 | $450K | Buy |
7,384
+3,095
| +72% | +$189K | 0.07% | 228 |
|
|
2021
Q4 | $282K | Buy |
4,289
+905
| +27% | +$59.5K | 0.06% | 280 |
|
|
2021
Q3 | $212K | Buy |
+3,384
| New | +$212K | 0.05% | 300 |
|
|
2020
Q1 | – | Sell |
-5,100
| Closed | -$225K | – | 260 |
|
|
2019
Q4 | $225K | Buy |
+5,100
| New | +$225K | 0.07% | 226 |
|